Edition:
United States

AMAG Pharmaceuticals Inc (AMAG.O)

AMAG.O on Nasdaq

8.87USD
25 Jun 2019
Change (% chg)

$0.31 (+3.62%)
Prev Close
$8.56
Open
$8.42
Day's High
$8.98
Day's Low
$7.81
Volume
2,812,336
Avg. Vol
816,342
52-wk High
$26.10
52-wk Low
$7.81

Select another date:

Fri, Jun 21 2019

Photo

FDA approves drug for loss of sexual desire in women

The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals' drug to restore sexual desire in premenopausal women, the latest attempt to come up with a therapy that some have dubbed as "female Viagra".

UPDATE 2-FDA approves drug for loss of sexual desire in women

June 21 The U.S. drug regulator on Friday approved Palatin Technologies and Amag Pharmaceuticals' drug to restore sexual desire in premenopausal women, the latest attempt to come up with a therapy that some have dubbed as "female Viagra".

FDA approves drug for loss of female sexual desire

June 21 The U.S. Food and Drug Administration on Friday approved Palatin Technologies Inc and Amag Pharmaceuticals Inc's drug to restore sexual desire in premenopausal women, Amag said.

Select another date: